Kathleen Giacomini

Kathleen M. Giacomini is a professor of bioengineering and therapeutic sciences at the University of California, San Francisco. Her work focuses on how genetics affects the efficacy of drugs.[1] She is also the co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering at the University of California, San Francisco.

Kathleen M. Giacomini
EducationUniversity at Buffalo
HonorsScheele Award (2011)

Giacomini has organized Health Care conferences in the San Francisco Bay Area [2]

Education

Giacomini earned her doctorate in pharmaceutics from the University at Buffalo. From 1979 to 81, Giacomini was a post-doctoral fellow in clinical pharmacology at Stanford University.[3]

Career

In 1998, Giacomini was named chair of the department of biopharmaceutical sciences at the University of California San Francisco.[4] In 1999, Giacomini became the first woman honored as Pharmaceutical Scientist of the Year by the International Pharmaceutical Federation.[5] In 2000, Giacomini organized the Pharmacogenomics of Membrane Transporters (PMT) Project at the University of California, San Francisco.[6] In 2005, while serving as vice chair of the Pharmacogenetics Research Network, Giacomini was awarded the Paul Dawson Biotechnology Award by the American Association of Colleges of Pharmacy.[4]

In 2010, Giacomini received the Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy.[7] The following year she was awarded the Scheele Award for her work on the pharmacogenetics of drug transporters.[8] In 2014, Giacomini became the co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering.[9][10]

In 2018, Giacomini was awarded the Bill Heller Mentor of the Year Award by the American Foundation for Pharmaceutical Education[11] and the Volwiler Research Award.[12]

References
  1. "2016 NIH Funding: A Look at Top Recipients and Their Research". University of California San Francisco. Retrieved 4 April 2019.
  2. "Federal shutdown cancels conference aimed at health care cooperation". Biz Journals. Retrieved 4 April 2019.
  3. Suzanne Chamberlain (March 29, 2002). "Noted Researcher to Speak on Drugs and Genes in the First Gerhard Levy Distinguished Lecture". buffalo.edu. Retrieved April 5, 2019.
  4. "Giacomini Receives Dawson Award". pharmacy.ucsf.edu. July 19, 2005. Retrieved April 5, 2019.
  5. "UCSF professor receives Pharmaceutical Scientist of the Year Award". eurekalert.org. September 6, 1999. Retrieved April 5, 2019.
  6. "Giacomini, Haines, Johnson, and Kane to Receive ACCP Honors". accp.com. Retrieved April 5, 2019.
  7. "Giacomini to receive Therapeutic Frontiers Lecture Award". pharmacy.ucsf.edu. October 14, 2010. Retrieved April 5, 2019.
  8. "The Scheele Award 2011 to Professor Kathleen M. Giacomini for her pioneering work on the pharmacogenetics of drug transporters". mynewsdesk.com. January 11, 2011. Retrieved April 5, 2019.
  9. Barry, Fiona (May 21, 2014). "US FDA founds regulatory science centre with UCSF and Stanford". .in-pharmatechnologist.com. Retrieved April 5, 2019.
  10. Ron Leuty (May 5, 2014). "Stanford, UCSF target better drug development in new FDA partnership". bizjournals.com. Retrieved April 5, 2019.
  11. Burningham, Grant (September 17, 2018). "Giacomini receives Bill Heller Mentor of the Year Award". pharmacy.ucsf.edu. Retrieved April 5, 2019.
  12. Burningham, Grant (April 16, 2018). "Giacomini named 2018 Volwiler Research Award recipient". pharmacy.ucsf.edu. Retrieved April 5, 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.